Panagiota Stamou

Suggest Changes
  • Citations Per Year
Learn More
BACKGROUND Major barriers in using classical FOXP3+ regulatory T cells (Tregs) in clinical practice are their low numbers in the circulation, the lack of specific cell surface markers for efficient(More)
  • 1